Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Toon Oomen"'
Autor:
Jean Noël Trochu, Vincent Probst, Jan J.J. Aalberts, Susan A. Slaugenhaupt, Elena Aikawa, Thierry Le Tourneau, Solena Le Scouarnec, Hubert Desal, Simon Lecointe, Francesca N. Delling, Christian Dina, Hervé Le Marec, Ousama Al Habash, Russell A. Norris, Roger R. Markwald, Toon Oomen, Xavier Jeunemaitre, Caroline Cueff, Albert J. H. Suurmeijer, Jonathan A. Bernstein, Robert A. Levine, F. Kyndt, Matilde Karakachoff, Jean Mérot, Romain Capoulade, Albert Hagège, David J. Milan, Jean Christian Roussel, Daniel Bernstein, Jean-Jacques Schott
Publikováno v:
European Heart Journal
European Heart Journal, Oxford University Press (OUP): Policy B, 2018, Equipe I, 39 (15), pp.1269--1277. ⟨10.1093/eurheartj/ehx505⟩
European Heart Journal, Oxford University Press (OUP): Policy B, 2018, 39 (15), pp.1269-1277. ⟨10.1093/eurheartj/ehx505⟩
European Heart Journal, 39(15), 1269-1277. Oxford University Press
European Heart Journal, 2018, Equipe I, 39 (15), pp.1269--1277. ⟨10.1093/eurheartj/ehx505⟩
European Heart Journal, Oxford University Press (OUP): Policy B, 2018, Equipe I, 39 (15), pp.1269--1277. ⟨10.1093/eurheartj/ehx505⟩
European Heart Journal, Oxford University Press (OUP): Policy B, 2018, 39 (15), pp.1269-1277. ⟨10.1093/eurheartj/ehx505⟩
European Heart Journal, 39(15), 1269-1277. Oxford University Press
European Heart Journal, 2018, Equipe I, 39 (15), pp.1269--1277. ⟨10.1093/eurheartj/ehx505⟩
International audience; Aims: Filamin-A (FLNA) was identified as the first gene of non-syndromic mitral valve dystrophy (FLNA-MVD). We aimed to assess the phenotype of FLNA-MVD and its impact on prognosis. Methods and results: We investigated the dis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c68e3b54a3a373b0bc35757bca696a95
https://hal.archives-ouvertes.fr/hal-01833318
https://hal.archives-ouvertes.fr/hal-01833318
Autor:
Lodewijk J. Wagenaar, Berto J. Bouma, Aeilko H. Zwinderman, Teun van der Bom, Toon Oomen, Joey M. Kuijpers, Folkert J. Meijboom, Jolien W. Roos-Hesselink, Hubert W. Vliegen, Wilfred F. Heesen, A. Carla Zomer, Annelieke C.M.J. van Riel, Petronella G. Pieper, Barbara J.M. Mulder, W. Marc Waskowsky, Arie P.J. van Dijk
Publikováno v:
European Heart Journal, 36, 2079-2086
European heart journal, 36(31), 2079-2086. Oxford University Press
European Heart Journal, 36(31), 2079-2086. Oxford University Press
European Heart Journal, 36, 31, pp. 2079-2086
European Heart Journal, 36(31), 2079-2086
European Heart Journal, 36(31), 2079. Oxford University Press
European heart journal, 36(31), 2079-2086. Oxford University Press
European Heart Journal, 36(31), 2079-2086. Oxford University Press
European Heart Journal, 36, 31, pp. 2079-2086
European Heart Journal, 36(31), 2079-2086
European Heart Journal, 36(31), 2079. Oxford University Press
Item does not contain fulltext AIMS: The identification of sex differences in the prognosis of adults with a secundum atrial septal defect (ASD2) could help tailor their clinical management, as it has in other cardiovascular diseases. We investigated
Autor:
Jan J.J. Aalberts, Maarten P. van den Berg, Jan D. H. Jongbloed, J. Peter van Tintelen, Albert J. H. Suurmeijer, Dicky J. J. Halley, Toon Oomen, Jorieke E. H. Bergman
Publikováno v:
American Journal of Medical Genetics Part A, 164(1), 113-119. Wiley-Liss Inc.
American Journal of Medical Genetics. Part B: Neuropsychiatric Genetics, 164(1), 113-119. Wiley
American Journal of Medical Genetics. Part B: Neuropsychiatric Genetics, 164(1), 113-119. Wiley
So far only mutations in the filamin A gene (FLNA) have been identified as causing familial mitral valve prolapse (MVP). Previous studies have linked dysregulation of the transforming growth factor beta (TGF-) cytokine family to MVP. We investigated
Autor:
Toon Oomen, J. Peter van Tintelen
Publikováno v:
Clinical Cardiogenetics ISBN: 9783319442020
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::859db904d69a7e6b1a4e591849c9d8a4
https://doi.org/10.1007/978-3-319-44203-7_20
https://doi.org/10.1007/978-3-319-44203-7_20
Publikováno v:
Clinical Cardiogenetics ISBN: 9781849964708
Clinical Cardiogenetics ISBN: 9783030454562
Clinical Cardiogenetics ISBN: 9783030454562
Mitral valve prolapse (MVP) is one of the most common forms of valvular heart disease. The clinical presentation can be very diverse, ranging from an incidental finding within asymptomatic patients to dramatic cases with severe mitral regurgitation,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6e12c6168bc076c58e2af376d896b06e
https://doi.org/10.1007/978-1-84996-471-5_15
https://doi.org/10.1007/978-1-84996-471-5_15
Autor:
Cathelijne Dickhoff, J. Peter van Tintelen, Bob G S Abeln, Karim Taha, Arjan C. Houweling, Arthur A.M. Wilde, Virginnio M Proost, Juan Ramón Gimeno-Blanes, Remco de Brouwer, Maarten P. van den Berg, Laurens P Bosman, Toon Oomen, Folkert W. Asselbergs, Tom E Verstraelen, Freyja H.M. van Lint, Aeilko H. Zwinderman, Bas A. Schoonderwoerd, Paul A. van der Zwaag, G.P. Kimman, Rudolf A. de Boer
Publikováno v:
Verstraelen, T E, Van Lint, F H M, Bosman, L P, De Brouwer, R, Proost, V M, Abeln, B G S, Taha, K, Zwinderman, A H, Dickhoff, C, Oomen, T, Schoonderwoerd, B A, Kimman, G P, Houweling, A C, Gimeno-Blanes, J R, Asselbergs, F W, Van Der Zwaag, P A, De Boer, R A, Van Den Berg, M P, Van Tintelen, J P & Wilde, A A M 2021, ' Prediction of ventricular arrhythmia in phospholamban p.Arg14del mutation carriers-reaching the frontiers of individual risk prediction ', European Heart Journal, vol. 42, no. 29, pp. 2842-2850 . https://doi.org/10.1093/eurheartj/ehab294
European Heart Journal, 42(29), 2842-2850. Oxford University Press
European Heart Journal, 42(29). Oxford University Press
European heart journal, 42(29), 2842-2850. Oxford University Press
European Heart Journal, 42(29), 2842-2850. Oxford University Press
European Heart Journal, 42(29). Oxford University Press
European heart journal, 42(29), 2842-2850. Oxford University Press
Aims This study aims to improve risk stratification for primary prevention implantable cardioverter defibrillator (ICD) implantation by developing a new mutation-specific prediction model for malignant ventricular arrhythmia (VA) in phospholamban (PL